What You Should Know:
– Qure.ai, a TIME100 most influential company and global leader in digital healthcare, today announced its collaboration with Microsoft. Qure.ai will onboard its end-to-end lung cancer detection, measurement and management suite of…
Continue Reading
Indian medical imaging AI company Qure.ai has developed a new AI-powered co-pilot for optimising resources in resource-constrained primary care settings.Called AIRA, this tool for community health workers is powered by large language models trained…
Continue Reading
Peninsula Imaging Network (PenRAD) has launched an AI-powered chest CT service across four NHS trusts in Devon, Cornwall and the Isles of Scilly to help detect lung cancer quicker.
Qure.ai’s AI for chest CT (qCT)…
What You Should Know:
– University Hospitals Cleveland Medical Center (UH) has announced a groundbreaking collaboration with global healthcare Artificial Intelligence (AI) innovator Qure.ai to deploy chest X-ray AI supporting earlier identification of lung cancers.
– The…
Continue Reading
Simon Rasalingham, chief executive of Behold.ai (Credit: Prix Galien International)
UK-based digital health start-up Behold.ai has entered administration after failing to win any contracts under the government’s AI Diagnostic Fund.
Behold.ai supplies lung cancer AI…
In this interview, Dr. Samir Shah, Chief Medical Officer at Qure.ai, shares why achieving FDA approval is crucial for their AI solutions and for fostering trust in the technology. Dr. Shah discusses how their…
Continue Reading
Jim Mercadante, Chief Commercial Officer at Qure.ai
What You Should Know:
– Qure.ai, a global provider of AI-powered healthcare solutions, announced the appointment of Jim Mercadante as its new Chief Commercial Officer.
– Based in New York,…
Continue Reading
Day 2 of the annual RSNA conference, #RSNA24, was all about education.The day started with a sit-down interview with Raj Chopra, MD from Merge by Merative who spoke about the need for radiologists to…
Continue Reading
North East London Cancer Alliance is leading a project to integrate AI into cancer diagnostic pathways, with the aim of reducing the wait time for chest X-ray results for scans with significant findings from…
Continue Reading
Qure.ai nets $65M for foundational AI Qure.ai has raised $65 million in a Series D funding round led by Lightspeed and 360 ONE Asset.
The company said it will use its fresh funds to invest more in foundational…
